NCT01851135View on ClinicalTrials.gov

Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1

NACompletedINTERVENTIONAL
Enrollment

286

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Neurofibromatosis Type 1
Interventions
OTHER

Neuropsychological examination and quality of life measures

Trial Locations (2)

44093

Centre Hospitalier Universitaire de Nantes, Nantes

94010

Assistance Publique - Hôpitaux de Paris (Hôpital Henri Mondor), Créteil

All Listed Sponsors
collaborator

Université d'Angers (Angers, France)

UNKNOWN

collaborator

Association Neurofibromatoses et Recklinghaüsen

UNKNOWN

lead

Nantes University Hospital

OTHER

NCT01851135 - Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1 | Biotech Hunter | Biotech Hunter